Notable Insider Trading: Lifevantage Corporation $LFVN

wall-street-621097_1920

Lifevantage Corporation (LFVN) insiders have most recently took part in a trading activity. On Sep 15, 2017 Lewis Darwin, Director bought 3,500 shares having total worth of $15,015 at the price of $4.29 per share, following the transaction a total of 3,500 shares owned by Lewis Darwin.

On the same day, Mauro Garry Paul, Director bought 3,500 shares having total worth of $14,700 at the price of $4.2 per share, following the transaction a total of 58,640 shares owned by Mauro Garry Paul. Before this latest buy, Mauro Garry Paul purchased LFVN at 1 other times during the past twelve months, for a total investment of $16,363 at an average of $6.72 per share.

The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 9 times by insiders. an employee of the company was the buyer in 9 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 1 0 -7.96%
12 Month 9 0 -51.25%

Shares of Lifevantage Corporation (LFVN) traded up 4.9% on Sep 15, 2017, hitting $4.28. 68,309 shares of the company’s stock traded hands. Lifevantage Corporation has a 52 week low of $2.92 and a 52 week high of $15.68. The company’s market cap is $145 million.

Lifevantage Corporation (LFVN) last announced its earnings results on Sep 7, 2017. The company reported 0.04 earnings per share (EPS) for the quarter. The company had revenue of $51 million for the quarter During the same quarter in the previous year, the company posted 0.22 earnings per share. The company’s revenue for the quarter was down 5% on a year-over-year basis.

2017-09-07 2017-05-10 2017-02-08 2016-12-12 2016-05-04 2016-02-09 2015-11-04 2015-09-01 2015-05-06 2015-02-04
earnings per share 0.04 0.02 0.11 0.13 0.14 0.14 0.08 0.00 0.01 0.01
Revenue(M) 50.64 45.01 48.95 54.89 56.16 52 45.35 45.3 45.2 48.25

Lifevantage Corporation was founded in 2003. It is a science based nutraceutical company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement Protandim(r), the Nrf2 Synergizer(r). LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. Protandim is a daily dietary supplement that combats oxidative stress through Nrf2 activation. Oxidative stress is inevitable for everyone. Protandim significantly reduces oxidative stress through Nrf2 activation. Nrf2 regulates survival genes. Comprised of natural plant ingredients, Protandim is a patented, science-based formula that has been researched, tested and validated by renowned universities and institutions. It is the only supplement clinically proven to reduce oxidative stress in humans by an average of 40 percent in 30 days. Protandim activates Nrf2, which communicates with cells, instructing them to do what they’re already designed to do: up-regulate “survival genes,” genes that enable cells to survive in the face of stress from free radicals and other oxidants, and down-regulate other genes that promote inflammation and fibrosis to help the body function at an optimal level. TrueScience Anti-Aging Cream provides the latest skin care technology. It targets the causes of aging, not just the signs. Its powerful anti-wrinkle formula boosts six skin-rebuilding essentials and contains the 11 ingredients described as the most effective in improving skin tone, texture and appearance.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.